ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Veit Scheble(University of Tübingen), Martin Braun(University of Tübingen), Rameen Beroukhim(Dana-Farber Cancer Institute), Craig H. Mermel(Dana-Farber Cancer Institute), Christian Ruiz(University Hospital of Basel), Theresia Wilbertz(University of Tübingen), Ann‐Cathrin Stiedl(University of Tübingen), Karen Petersen(University of Tübingen), Markus Reischl, Rainer Kuefer(University Hospital Ulm), David Schilling(University of Tübingen), Falko Fend(University of Tübingen), Glen Kristiansen(University Hospital of Zurich), Matthew Meyerson(Brigham and Women's Hospital), Mark A. Rubin(Cornell University), Lukas Bubendorf(University Hospital of Basel), Sven Perner(University of Tübingen)
Cited by 121Open Access
Abstract
Related Papers
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Sven Perner, Juan Miguel Mosquera, Francesca Demichelis et al.|The American Journal of Surgical Pathology|2007|431